Cannabix Technologies Inc. (BLOZF)
USD 0.24
(0.42%)
USD 0.24
(0.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -3.12 Million CAD | -46.23% |
| 2023 | -2.13 Million CAD | 36.51% |
| 2022 | -3.36 Million CAD | 63.57% |
| 2021 | -9.24 Million CAD | -32.6% |
| 2020 | -6.97 Million CAD | -79.64% |
| 2019 | -3.88 Million CAD | -164.33% |
| 2018 | -1.46 Million CAD | 60.67% |
| 2017 | -3.73 Million CAD | -307.07% |
| 2016 | -916.83 Thousand CAD | 48.17% |
| 2015 | -1.76 Million CAD | -251.4% |
| 2014 | -503.4 Thousand CAD | -543.05% |
| 2013 | -78.28 Thousand CAD | 64.43% |
| 2012 | -220.07 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -1.18 Million CAD | -164.46% |
| 2024 Q1 | -577.79 Thousand CAD | -69.71% |
| 2024 Q2 | -920.43 Thousand CAD | -59.3% |
| 2024 Q3 | -446.79 Thousand CAD | 51.46% |
| 2024 FY | -3.12 Million CAD | -46.23% |
| 2023 Q1 | -555.84 Thousand CAD | 13.13% |
| 2023 FY | -2.13 Million CAD | 36.51% |
| 2023 Q4 | -340.46 Thousand CAD | 50.18% |
| 2023 Q2 | -558.41 Thousand CAD | -0.46% |
| 2023 Q3 | -683.38 Thousand CAD | -22.38% |
| 2022 Q3 | -1.59 Million CAD | -167.33% |
| 2022 Q1 | -538.19 Thousand CAD | -3.25% |
| 2022 FY | -3.36 Million CAD | 63.57% |
| 2022 Q4 | -639.86 Thousand CAD | 59.85% |
| 2022 Q2 | -596.1 Thousand CAD | -10.76% |
| 2021 FY | -9.24 Million CAD | -32.6% |
| 2021 Q3 | -7.17 Million CAD | -1554.56% |
| 2021 Q1 | -1.1 Million CAD | 75.28% |
| 2021 Q2 | -433.85 Thousand CAD | 60.91% |
| 2021 Q4 | -521.23 Thousand CAD | 92.74% |
| 2020 Q3 | -523.43 Thousand CAD | 63.1% |
| 2020 Q4 | -4.48 Million CAD | -757.76% |
| 2020 FY | -6.97 Million CAD | -79.64% |
| 2020 Q1 | -538.43 Thousand CAD | 33.03% |
| 2020 Q2 | -1.41 Million CAD | -163.44% |
| 2019 Q2 | -2.24 Million CAD | -624.38% |
| 2019 FY | -3.88 Million CAD | -164.33% |
| 2019 Q3 | -524.4 Thousand CAD | 76.62% |
| 2019 Q4 | -803.98 Thousand CAD | -53.31% |
| 2019 Q1 | -309.57 Thousand CAD | 35.14% |
| 2018 Q2 | -357.39 Thousand CAD | -20.47% |
| 2018 FY | -1.46 Million CAD | 60.67% |
| 2018 Q3 | -336.65 Thousand CAD | 5.8% |
| 2018 Q1 | -296.67 Thousand CAD | 75.48% |
| 2018 Q4 | -477.32 Thousand CAD | -41.79% |
| 2017 Q4 | -1.21 Million CAD | 19.27% |
| 2017 Q3 | -1.49 Million CAD | -560.5% |
| 2017 Q1 | -796.06 Thousand CAD | -150.33% |
| 2017 Q2 | -226.95 Thousand CAD | 71.49% |
| 2017 FY | -3.73 Million CAD | -307.07% |
| 2016 Q1 | -179.66 Thousand CAD | 72.22% |
| 2016 Q3 | -218.98 Thousand CAD | -9.4% |
| 2016 FY | -916.83 Thousand CAD | 48.17% |
| 2016 Q4 | -318.01 Thousand CAD | -45.22% |
| 2016 Q2 | -200.17 Thousand CAD | -11.41% |
| 2015 FY | -1.76 Million CAD | -251.4% |
| 2015 Q4 | -646.67 Thousand CAD | -136.85% |
| 2015 Q3 | -273.02 Thousand CAD | -43.67% |
| 2015 Q2 | -190.03 Thousand CAD | 71.17% |
| 2015 Q1 | -659.23 Thousand CAD | -113.38% |
| 2014 Q3 | -107.27 Thousand CAD | -58.31% |
| 2014 Q4 | -308.94 Thousand CAD | -187.99% |
| 2014 Q2 | -67.76 Thousand CAD | -249.06% |
| 2014 Q1 | -19.41 Thousand CAD | 66.14% |
| 2014 FY | -503.4 Thousand CAD | -543.05% |
| 2013 Q1 | -7965.00 CAD | 0.0% |
| 2013 FY | -78.28 Thousand CAD | 64.43% |
| 2013 Q4 | -57.33 Thousand CAD | -1141.1% |
| 2013 Q3 | -4620.00 CAD | 44.73% |
| 2013 Q2 | -8359.00 CAD | -4.95% |
| 2012 FY | -220.07 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.16 Million USD | 92.017% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -168.378% |
| Össur hf. | 58.38 Million USD | 105.355% |
| QHSLab, Inc. | -468.36 Thousand USD | -567.562% |
| Wellstar International, Inc. | -3.1 Million USD | -0.584% |
| Össur hf. | 58.38 Million USD | 105.355% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | -125.26 Thousand USD | -2396.074% |
| Aurora Spine Corporation | -1.68 Million USD | -86.045% |
| BrainsWay Ltd. | -4.19 Million USD | 25.504% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -332.562% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -415.073% |
| Vivos Inc. | -2.89 Million USD | -8.009% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -1331.131% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -75.866% |
| Zecotek Photonics Inc. | -3.51 Million USD | 11.15% |
| Avitar, Inc. | -2.25 Million USD | -38.368% |
| Nanomix Corporation | -12.33 Million USD | 74.648% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 232.934% |
| Theraclion SA | -3.67 Million USD | 14.922% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -1.63 Million USD | -90.798% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | -18.376% |
| Lombard Medical, Inc. | -31.03 Million USD | 89.926% |
| ALR Technologies Inc. | -11.89 Million USD | 73.719% |
| Stratec SE | 14.42 Million USD | 121.674% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -4386.386% |
| Heart Tronics, Inc. | -13.32 Million USD | 76.54% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.345% |
| VMS Rehab Systems, Inc. | 46.44 USD | 6732673.213% |
| NewCardio, Inc. | -11.49 Million USD | 72.803% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 10.387% |
| Ingen Technologies, Inc. | -5.06 Million USD | 38.227% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -245.187% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -647.933% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -315.231% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 87.885% |
| IR-Med Inc. | -4.9 Million USD | 36.309% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 77.724% |
| Polarean Imaging plc | -11.88 Million USD | 73.692% |
| United American Healthcare Corporation | 723 Thousand USD | 532.449% |
| ECGI Holdings, Inc. | -3.61 Million USD | 13.412% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -2390.804% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -375.151% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -336.159% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 891.867% |
| Urologix, Inc. | -7.6 Million USD | 58.904% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | -84.591% |
| Nexeon MedSystems Inc. | -2.17 Million USD | -43.578% |
| SS Innovations International, Inc. | -20.94 Million USD | 85.07% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -288.388% |
| Smith & Nephew plc | 263 Million USD | 101.189% |
| NIOX Group Plc | 13.64 Million USD | 122.922% |
| Fuse Medical, Inc. | 1.45 Million USD | 314.156% |
| Broncus Holding Corporation | -28.09 Million USD | 88.87% |
| Brain Scientific Inc. | -12.34 Million USD | 74.671% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 89.334% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -1851.105% |